CNTO-3157

N/A

Report date: 2024/03/01 20:05:21

Base Information

Drug NameCNTO-3157
Drug Alias NameJNJ-42915925CNTO-3157PRV-300
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionToll like receptor 3 antagonists
TargetsToll like receptor 3
Therapy Area/IndicationsAsthmaColitis, Ulcerative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[10] 
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMorphosys AgCentocor Ortho Biotech Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesProvention Bio IncJanssen Research & Development LlcCentocor Inc
Active IndicationsN/A
Inactive IndicationsAsthmaColitis, Ulcerative

Other Information

ATC CodeN/A
Related LinksN/A